Depakote ER is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Divalproex Sodium.
| Product ID | 70518-1759_7e80dcd1-a8ea-d229-e053-2991aa0a5377 |
| NDC | 70518-1759 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Depakote ER |
| Generic Name | Divalproex Sodium |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021168 |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | DIVALPROEX SODIUM |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-01-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021168 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-02 |
| Ingredient | Strength |
|---|---|
| DIVALPROEX SODIUM | 500 mg/1 |
| SPL SET ID: | ea5681e8-bc5a-429d-ba85-b04c527c1cdd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 70518-1758 | Depakote ER | Depakote ER |
| 70518-1759 | Depakote ER | Depakote ER |
| 43353-310 | Depakote ER | Depakote ER |
| 63629-3370 | Depakote ER | Depakote ER |
| 0074-3826 | Depakote | Divalproex Sodium |
| 0074-6114 | Depakote | Divalproex Sodium |
| 0074-6212 | Depakote | Divalproex Sodium |
| 0074-6214 | Depakote | Divalproex Sodium |
| 0074-6215 | Depakote | Divalproex Sodium |
| 0074-7126 | Depakote | Divalproex Sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DEPAKOTE 75295484 2197507 Dead/Cancelled |
SANOFI-AVENTIS 1997-05-21 |
![]() DEPAKOTE 73383028 1377834 Live/Registered |
SANOFI 1982-09-01 |